About
Sonavex is a medical device company based in Baltimore, founded in 2013 as a spin-off from Johns Hopkins University. The company focuses on enhancing hemodialysis patient care through innovative ultrasound technologies. Their primary products, EchoMark and EchoSure, are designed to improve the assessment of arteriovenous fistulas (AVFs) used in dialysis. EchoMark is a bioresorbable implant that enhances the visibility of the AVF on ultrasound, allowing care teams to quickly locate the fistula and gather essential data. EchoSure is an AI-enhanced ultrasound device that works with EchoMark to provide critical parameters such as AVF volumetric flow rate, diameter, and depth. Together, these technologies enable healthcare providers to collect accurate AVF data easily, facilitating better treatment decisions and potentially reducing complications. Sonavex aims to empower clinicians and improve patient outcomes while delivering cost savings to the healthcare system. Their user-friendly system is designed for a wide range of healthcare professionals involved in dialysis care, supporting effective patient monitoring and management.
Technologies
Keywords
Company Information
-
Employees 24
-
Founded 2013
-
Annual Revenue $3000000
-
Total Funding $89270192
Location
2835 O Donnell Street, Baltimore, Maryland, United States, 21224